Attention, inhibition, and proximity to clinical onset in preclinical mutation carriers for Huntington's disease

Journal of Clinical and Experimental Neuropsychology

Volumn 29, Issue 3, 2007, Pages 235-246

  Farrow, Maree ^a   Churchyard, Andrew ^b   Chua, Phyllis ^a   Bradshaw, John L ^a   Chiu, Edmond ^c   Georgiou Karistianis, Nellie ^a  

^a MONASH UNIVERSITY   (Australia)

^b Calvary Health Care Bethlehem ^*  (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASSOCIATION; ATTENTION; BLINKING; CLINICAL ARTICLE; FEMALE; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; MALE; PRIORITY JOURNAL; TACTILE STIMULATION; TASK PERFORMANCE; VISUAL ORIENTATION; VISUAL STIMULATION;

ADULT; AGE OF ONSET; ATTENTION; BLINKING; CUES; FEMALE; HUMANS; HUNTINGTON DISEASE; INHIBITION (PSYCHOLOGY); MALE; MUTATION; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REPETITIVE SEQUENCES, NUCLEIC ACID; TOUCH; VIBRATION;

EID: 34247170302     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803390600657693     Document Type: Article

References (56)

1. Andrews, T. C., Weeks, R. A., Turjanski, N., Gunn, R. N., Watkins, L. H., Sahakian, B., et al. (1999). Huntington's disease progression: PET and clinical observations. Brain, 122, 2353-2363.
2. Antonini, A., Leenders, K. L., Spiegel, R., Meier, D., Vontobel, P., Weigell-Weber, M., et al. (1996). Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain, 119, 2085-2095.
3. Aron, A. R., Sahakian, B. J., & Robbins, T. W. (2003). Distractibility during selection-for-action: Differential deficits in Huntington's disease and following frontal lobe damage. Neuropsychologia, 41, 1137-1147.
4. Aylward, E. H., Codori, A. M., Rosenblatt, A., Sherr, M., Brandt, J., Stine, O. C., et al. (2000). Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Movement Disorders, 15, 552-560.
5. Aylward, E. H., Sparks, B. F., Field, K. M., Yallapragada, V., Shpritz, B. D., Rosenblatt, A., et al. (2004). Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology, 63, 66-72.
6. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 53-63.
7. Bradshaw, J. L., Waterfall, M. L., Phillips, J. G., Iansek, R., Mattingley, J. B., & Bradshaw, J. A. (1993). Reorientation of attention in Parkinson's disease: An extension to the vibrotactile modality. Neuropsychologia, 31, 51-66.
8. Campodonico, J. R., Aylward, E., Codori, A. M., Young, C., Krafft, L., Magdalinski, M., et al. (1998). When does Huntington's disease begin? Journal of the International Neuropsychological Society, 4, 467-473.
9. Campodonico, J. R., Codori, A. M., & Brandt, J. (1996). Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation. Journal of Neurology, Neurosurgery and Psychiatry, 61, 621-624.
10. Connolly, J. D., Goodale, M. A., Desouza, J. F., Menon, R. S., & Vilis, T. (2000). A comparison of frontoparietal fMRI activation during anti-saccades and anti-pointing. Journal of Neurophysiology, 84, 1645-1655.
11. Corbetta, M. (1998). Frontoparietal cortical networks for directing attention and the eye to visual locations: Identical, independent, or overlapping neural systems? Proceedings of the National Academy of Sciences of the USA, 95, 831-838.
12. De Boo, G. M., Tibben, A., Lanser, J. B. K., Jennekens-Schinkel, A., Hermans, J., Maat-Kievit, A., et al. (1997). Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease. Archives of Neurology, 54, 1353-1357.
13. Fielding, J., Georgiou-Karistianis, N., Bradshaw, J., Millist, L., Churchyard, A., Chiu, E., et al. (2006). Accelerated time-course of IOR in Huntington's disease. Manuscript submitted for publication.
14. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
15. Georgiou, N., Bradshaw, J. L., Phillips, J. G., Bradshaw, J. A., & Chiu, E. (1995). The Simon effect and attention deficits in Gilles de la Tourette's syndrome and Huntington's disease. Brain, 118, 1305-1318.
16. Georgiou, N., Bradshaw, J. L., Phillips, J. G., & Chiu, E. (1997). Effect of directed attention in Huntington's disease. Journal of Clinical and Experimental Neuropsychology, 19, 367-377.
17. Georgiou-Karistianis, N., Smith, E., Bradshaw, J. L., Chua, P., Lloyd, J., Churchyard, A., et al. (2003). Future directions in research with presymptomatic individuals carrying the gene for Huntington's disease. Brain Research Bulletin, 59, 331-338.
18. Giordani, B., Berent, S., Boivin, M. J., Penney, J. B., Lehtinen, S., Markel, D. S., et al. (1995). Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease. Archives of Neurology, 52, 59-64.
19. Gomez-Tortosa, E., del Barrio, A., Barroso, T., & Garcia Ruiz, P. J. (1996). Visual processing disorders in patients with Huntington's disease and asymptomatic carriers. Journal of Neurology, 243, 286-292.
20. Hahn-Barma, V., Deweer, B., Durr, A., Dode, C., Feingold, J., Pillon, B., et al. (1998). Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. Journal of Neurology, Neurosurgery and Psychiatry, 64, 172-177.
21. Huntington's Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
22. Huntington's Disease Study Group. (1996). Unified Huntington's disease rating scale: Reliability and consistency. Movement Disorders, 11, 136-142.
23. Jason, G. W., Suchowersky, O., Pajurkova, E. M., Graham, L., Klimek, M. L., Garber, A. T., et al. (1997). Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. Archives of Neurology, 54, 1081-1088.
24. Joel, D. (2001). Open interconnected model of basal ganglia- thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease. Movement Disorders, 16, 407-423.
25. Kipps, C. M., Duggins, A. J., Mahant, N., Gomes, L., Ashburner, J., & McCusker, E. A. (2005). Progression of structural neuropathology in preclinical Huntington's disease: A tensor based morphometry study. Journal of Neurology, Neurosurgery, and Psychiatry, 76, 650-655.
26. Klein, R. M. (2000). Inhibition of return. Trends in Cognitive Sciences, 4, 138-147.
27. Lang, C. J. G., Majer, M., Balan, P., & Reischies, F. M. (2000). Recall and recognition in Huntington's disease. Archives of Clinical Neuropsychology, 15, 361-371.
28. Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., & Hayden, M. R. (2004). A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics, 65, 267-277.
29. Lasker, A. G., & Zee, D. S. (1997). Ocular motor abnormalities in Huntington's disease. Vision Research, 37, 3639-3645.
30. Lawrence, A. D., Hodges, J. R., Rosser, A. E., Kershaw, A., ffrench-Constant, C., Rubinsztein, D. C., et al. (1998). Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain, 121, 1329-1341.
31. Lawrence, A. D., Watkins, L. H. A., Sahakian, B. J., Hodges, J. R., & Robbins, T. W. (2000). Visual object and visuospatial cognition in Huntington's disease: Implications for information processing in corticostriatal circuits. Brain, 123, 1349-1364.
32. Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G., Vandenbussche, E., & Dom, R. (2002). Longitudinal study evaluating neuropsychological changes in socalled asymptomatic carriers of the Huntington's disease mutation after 1 year. Acta Neurologica Scandinavica, 106, 131-141.
33. Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G., Vandenbussche, E., & Dom, R. (2004). Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation. A longitudinal follow-up study. Journal of Neurology, 251, 935-942.
34. Marcantoni, W. S., Chun, M. M., & Gore, F. (2003). Neural correlates of dual task interference in rapid visual streams: An fMRI study. Brain and Cognition, 53, 318-321.
35. Marois, R., Chun, M. M., & Gore, J. C. (2000). Neural correlates of the attentional blink. Neuron, 28, 299-308.
36. Microsoft Corporation. (1991). QBasic (Version 1.1) [Computer software.] Redmond, WA: Microsoft Corporation.
37. Mink, J. W. (1996). The basal ganglia: focussed selection and inhibition of competing motor programs. Progress in Neurobiology, 50, 381-425.
38. Muller, S. V., Jung, A., Preinfalk, J., Kolbe, H., Ridao-Alonso, M., Dengler, R., et al. (2002). Disturbance of "extrinsic alertness" in Huntington's disease. Journal of Clinical and Experimental Neuropsychology, 24, 517-526.
39. Nelson, H. E. (1982). National adult reading test (NART): Test manual. Windsor, UK: NFER-Nelson.
40. Paulsen, J. S., Zhao, H., Stout, J. C., Brinkman, R. R., Guttman, M., Ross, C. A., et al. (2001). Clinical markers for early disease in persons near onset of Huntington's disease. Neurology, 57, 658-662.
41. Paulsen, J. S., Zimbelman, J. L., Hinton, S. C., Langbehn, D. R., Leveroni, C. L., Benjamin, M. L., et al. (2004). fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. American Journal of Neuroradiology, 25, 1715-1721.
42. Posner, M. I., & Cohen, Y. (1984). Components of visual orienting. In H. Bouma & D. Bouwhuis (Eds.), Attention and performance Vol. X (pp. 531-556). Hove, UK: Lawrence Erlbaum Associates, Ltd.
43. Posner, M. I., & Raichle, M. E. (1996). Images of mind. New York: Scientific American Library.
44. Psychology Software Tools. (1999). E-prime (Version 1.0) [Computer software.] Pittsburgh, PA: Psychology Software Tools.
45. Raymond, J. E., Shapiro, K. L., & Arnell, K. M. (1992). Temporary suppression of visual processing in an RSVP task: An attentional blink? Journal of Experimental Psychology: Human Perception and Performance, 18, 849-860.
46. Reading, S. A. J., Dziorny, A. C., Peroutka, L. A., Schreiber, M., Gourley, L. M., Yallapragada, V., et al. (2004). Functional brain changes in presymptomatic Huntington's disease. Annals of Neurology, 55, 879-883.
47. Roman, M. J., Delis, D. C., Filoteo, J. V., Demadura, T. L., Paulsen, J., Swerdlow, N. R., et al. (1998). Is there a "subcortical" profile of attentional dysfunction? A comparison of patients with Huntington's and Parkinson's diseases on a global-local focussed attention task. Journal of Clinical and Experimental Neuropsychology, 20, 873-884.
48. Rosenberg, N. K., Sorensen, S. A., & Christensen, A. (1995). Neuropsychological characteristics of Huntington's disease carriers: A double blind study. Journal of Medical Genetics, 32, 600-604.
49. Rothlind, J. C., Bylsma, F. W., Peyser, C. P., Folstein, S. E., & Brandt, J. (1993). Cognitive and motor correlates of everyday functioning in early Huntington's disease. The Journal of Nervous and Mental Disease, 181, 194-199.
50. Snowden, J., Craufurd, D., Griffiths, H., Thompson, J., & Neary, D. (2001). Longitudinal evaluation of cognitive disorder in Huntington's disease. Journal of the International Neuropsychological Society, 7, 33-44.
51. Sprengelmeyer, R., Lange, H., & Homberg, V. (1995). The pattern of attentional deficits in Huntington's disease. Brain, 118, 145-152.
52. Thieben, M. J., Duggins, A. J., Good, C. D., Gomes, L., Mahant, N., Richards, F., et al. (2002). The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain, 125, 1815-1828.
53. Vardy, Y., Bradshaw, J. L., & Iansek, R. (2003). Dual target identification and the attentional blink in Parkinson's disease. Journal of Clinical and Experimental Neuropsychology, 25, 361-375.
54. Winograd-Gurvich, C. T., Georgiou-Karistianis, N., Evans, A., Millist, L., Bradshaw, J. L., Churchyard, A., et al. (2003). Hypometric primary saccades and increased variability in visually-guided saccades in Huntington's disease. Neuropsychologia, 41, 1683-1692.
55. Witjes-Ane, M. N., Vegter-van der Vlis, M., van Vugt, J. P., Lanser, J. B., Hermans, J., Zwinderman, A. H., et al. (2003). Cognitive and motor functioning in gene carriers for Huntington's disease: A baseline study. The Journal of Neuropsychiatry and Clinical Neurosciences, 15, 7-16.
56. Zakzanis, K. K. (1998). The subcortical dementia of Huntington's disease. Journal of Clinical and Experimental Neuropsychology, 20, 565-578.